Sleeping Pills (Prescription Drugs) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4149768
- 107 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Sleeping Pills (Prescription Drugs) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Sleeping Pills (Prescription Drugs) market segmented into
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Based on the end-use, the global Sleeping Pills (Prescription Drugs) market classified into
Hospital Pharmacy
Retail Pharmacy
Based on geography, the global Sleeping Pills (Prescription Drugs) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SLEEPING PILLS (PRESCRIPTION DRUGS) INDUSTRY
2.1 Summary about Sleeping Pills (Prescription Drugs) Industry
2.2 Sleeping Pills (Prescription Drugs) Market Trends
2.2.1 Sleeping Pills (Prescription Drugs) Production & Consumption Trends
2.2.2 Sleeping Pills (Prescription Drugs) Demand Structure Trends
2.3 Sleeping Pills (Prescription Drugs) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Zolpidem
4.2.2 Eszopiclone (Lunesta)
4.2.3 Ramelteon (Rozerem)
4.2.4 Ativan (lorazepam)
4.2.5 Adapin (doxepin)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacy
4.3.2 Retail Pharmacy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Zolpidem
5.2.2 Eszopiclone (Lunesta)
5.2.3 Ramelteon (Rozerem)
5.2.4 Ativan (lorazepam)
5.2.5 Adapin (doxepin)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Zolpidem
6.2.2 Eszopiclone (Lunesta)
6.2.3 Ramelteon (Rozerem)
6.2.4 Ativan (lorazepam)
6.2.5 Adapin (doxepin)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Zolpidem
7.2.2 Eszopiclone (Lunesta)
7.2.3 Ramelteon (Rozerem)
7.2.4 Ativan (lorazepam)
7.2.5 Adapin (doxepin)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Zolpidem
8.2.2 Eszopiclone (Lunesta)
8.2.3 Ramelteon (Rozerem)
8.2.4 Ativan (lorazepam)
8.2.5 Adapin (doxepin)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Zolpidem
9.2.2 Eszopiclone (Lunesta)
9.2.3 Ramelteon (Rozerem)
9.2.4 Ativan (lorazepam)
9.2.5 Adapin (doxepin)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi
10.1.2 Abbott Laboratories
10.1.3 Takeda Pharmaceutical
10.1.4 Apotex
10.1.5 Aurobindo Pharma
10.1.6 Actellon Pharmaceuticals
10.1.7 Allegiant Health
10.1.8 Cayman Chemical
10.1.9 Ambitropin
10.1.10 Hayao
10.2 Sleeping Pills (Prescription Drugs) Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi
10.2.2 Abbott Laboratories
10.2.3 Takeda Pharmaceutical
10.2.4 Apotex
10.2.5 Aurobindo Pharma
10.2.6 Actellon Pharmaceuticals
10.2.7 Allegiant Health
10.2.8 Cayman Chemical
10.2.9 Ambitropin
10.2.10 Hayao
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Sleeping Pills (Prescription Drugs) Product Type Overview
Table Sleeping Pills (Prescription Drugs) Product Type Market Share List
Table Sleeping Pills (Prescription Drugs) Product Type of Major Players
Table Brief Introduction of Sanofi
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Takeda Pharmaceutical
Table Brief Introduction of Apotex
Table Brief Introduction of Aurobindo Pharma
Table Brief Introduction of Actellon Pharmaceuticals
Table Brief Introduction of Allegiant Health
Table Brief Introduction of Cayman Chemical
Table Brief Introduction of Ambitropin
Table Brief Introduction of Hayao
Table Products & Services of Sanofi
Table Products & Services of Abbott Laboratories
Table Products & Services of Takeda Pharmaceutical
Table Products & Services of Apotex
Table Products & Services of Aurobindo Pharma
Table Products & Services of Actellon Pharmaceuticals
Table Products & Services of Allegiant Health
Table Products & Services of Cayman Chemical
Table Products & Services of Ambitropin
Table Products & Services of Hayao
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) by Region 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Sleeping Pills (Prescription Drugs) Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
